» Articles » PMID: 32916592

The Quality of General Movements in Infants with Complex Congenital Heart Disease Undergoing Surgery in the Neonatal Period

Overview
Journal Early Hum Dev
Publisher Elsevier
Date 2020 Sep 11
PMID 32916592
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Advances in diagnostic technologies, surgical management, and perioperative care have increased survival for neonates with complex congenital heart disease (CCHD). The success of these advances exposed a heightened risk of brain injury and developmental disabilities. The General Movements Assessment, a non-invasive method, may detect early neurodevelopmental impairments in high-risk infants.

Aims: To examine whether infants with CCHD undergoing neonatal surgery have higher prevalence of atypical general movements (GMs) than a reference group, and whether single ventricle physiology with systemic oxygen saturations <90% increases risk for atypical GMs.

Methods: Serial General Movements Assessment (GMA) in a cohort of infants with CCHD (n = 74) at writhing (term-6 weeks) and fidgety (7-17 weeks) GM-age. GMA focused on the presence of definitely abnormal GM-complexity and absent fidgety movements. Single GMAs at 3 months were available from a reference sample of Dutch infants (n = 300). Regression analyses examined relationships between cardiac characteristics and definitely abnormal GM-complexity.

Results: Higher prevalence of definitely abnormal GM-complexity in infants with CCHD compared to reference infants (adjusted OR 5.938, 95% CI 2.423-14.355), single ventricle CCHD increased the risk. Occurrence of absent fidgety movements was similar in infants with CCHD and reference infants (adjusted OR 0.475, 95% CI 0.058-3.876). Systemic postoperative oxygen saturations <90% was associated with higher risk of definitely abnormal GM-complexity at fidgety (adjusted OR 16.445 95% CI 1.149-235.281), not at writhing age.

Conclusions: Infants with CCHD, especially those with single ventricle CCHD, are at increased risk of definitely abnormal GM-complexity. GMA at fidgety age is recommended.

Citing Articles

Developmental care pathway for hospitalised infants with CHD: on behalf of the Cardiac Newborn Neuroprotective Network, a Special Interest Group of the Cardiac Neurodevelopmental Outcome Collaborative.

Lisanti A, Vittner D, Peterson J, Van Bergen A, Miller T, Gordon E Cardiol Young. 2023; 33(12):2521-2538.

PMID: 36994672 PMC: 10544686. DOI: 10.1017/S1047951123000525.


Growth and risk of adverse neuro-developmental outcome in infants with congenital heart disease: A systematic review.

Trivedi A, Browning Carmo K, Jatana V, James-Nunez K, Gordon A Acta Paediatr. 2022; 112(1):53-62.

PMID: 36203274 PMC: 10092319. DOI: 10.1111/apa.16564.


Motor development in infants with complex congenital heart disease: A longitudinal study.

Huisenga D, la Bastide-van Gemert S, Van Bergen A, Sweeney J, Hadders-Algra M Dev Med Child Neurol. 2022; 65(1):117-125.

PMID: 35665492 PMC: 10084079. DOI: 10.1111/dmcn.15287.


Neuromonitoring, neuroimaging, and neurodevelopmental follow-up practices in neonatal congenital heart disease: a European survey.

Feldmann M, Hagmann C, Vries L, Disselhoff V, Pushparajah K, Logeswaran T Pediatr Res. 2022; 93(1):168-175.

PMID: 35414671 PMC: 9876786. DOI: 10.1038/s41390-022-02063-2.


Screening and Evaluation of Neurodevelopmental Impairments in Infants Under 6 Months of Age with Congenital Heart Disease.

Tripathi T, Harrison T, Simsic J, Invencao Cabral T, Heathcock J Pediatr Cardiol. 2022; 43(3):489-496.

PMID: 35190880 DOI: 10.1007/s00246-021-02745-4.